Ongericimab Injection Reducing Recurrence of Ischemic Stroke

Clinical trial NCT07242599 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07242599
Sponsor: Beijing Tiantan Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ischemic Cerebral Infarction

Start date: 2026-04-22
Primary completion: 2029-04-01
Enrollment: 4810

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.